FreeGuest Editorial When your harmonica player wins the Nobel Prize October 05, 2018Vol.44 No.37By Rachel Humphrey
Guest Editorial The Trump administration “American Patients First” plan to reduce drug prices—Are American cancer patients first? June 15, 2018Vol.44 No.24By Hagop M. Kantarjian and Mary Alma Welch
FreeGuest Editorial Beyond #MeToo:Sexual Harassment in Biomedicine March 09, 2018Vol.44 No.10By Kelly McBride Folkers
FreeGuest Editorial A unique drug for each patient:a paradigm shift in cancer therapy January 19, 2018Vol.44 No.03By Steven A. Rosenberg
Guest Editorial Tobacco companies finally have to say smoking causes cancer December 08, 2017Vol.43 No.45By Cliff Douglas
FreeGuest Editorial The Write Treatment; when a writing workshop is a part of cancer treatment October 06, 2017Vol.43 No.37By Emily Rubin
Guest Editorial A costly “rebranding” of an old drug comes with a 700% price increase September 29, 2017Vol.43 No.36By Jason Funaro, Henry S. Friedman and Mallika Weant
FreeGuest Editorial How the RACE for Children Act will get drugs to kids with cancer September 08, 2017Vol.43 No.33By Nancy Goodman
Guest Editorial Senate passes a “right to try” bill; Harm to patients comes next August 04, 2017Vol.43 No.31By Kelly McBride Folkers, Lisa Kearns and Alison Bateman-House
FreeGuest Editorial Medical research funding: Why we must keep our foot on the accelerator July 21, 2017Vol.43 No.29By Michael A. Caligiuri
